Podcast

Episódio 32: Coronavírus Parte 2.2: Pandemia

00:00 00:00
skip_previous replay_10
forward_10 skip_next

Descrição

Ouça e se atualize sobre o novo Coronavírus com o TdC! O episódio foi dividido em duas partes, essa discute como está ocorrendo a pandemia e as medidas que podemos utilizar para o seu controle.


MINUTAGEM

[0:30] Situação Atual

[02:20] Letalidade

[06:00] Brasil vs Itália

[09:30] Quarentena e Isolamento

[15:00] Transmissão assintomática

[17:40] Medidas Não Farmacológicas

[28:00] Persistência do COVID-19 nas superfícies

[30:30] IECA/BRA/Ibuprofeno

[33:00] Crianças

[34:10] Salves


REFERÊNCIAS:

1. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. Published online February 24, 2020. doi:10.1001/jama.2020.2648

2. RUSSELL, Clark D.; MILLAR, Jonathan E.; BAILLIE, J. Kenneth. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. The Lancet, v. 395, n. 10223, p. 473-475, 2020. FANG, Lei;

3. KARAKIULAKIS, George; ROTH, Michael. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?. The Lancet Respiratory Medicine, 2020.

4. LIU, Weiyong et al. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China. New England Journal of Medicine, 2020.

5. Sociedade internacional de ultrassom em GO ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol. 2020 Mar 11. doi: 10.1002/uog.22013.

6. FAVRE, Guillaume et al. Guidelines for pregnant women with suspected SARS-CoV-2 infection. The Lancet Infectious Diseases, 2020.

7. CHEN, Huijun et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The Lancet, 2020.

8. Casadevall A, Pirofski LA. The convalescent sera option for containing COVID-19. J Clin Invest. 2020 Mar 13. pii: 138003. doi: 10.1172/JCI138003.

9. Advice on the use of masks in the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak Interim guidance 29 January 2020 - World Health Organization.

10. Advice on the use of masks in the community, during home care and in health care settings in the context of the novel coronavirus (2019-nCoV) outbreak. Interim guidance 29 January 2020. WHO reference number: WHO/nCov/IPC_Masks/2020.

11. Home care for patients with COVID-19 presenting with mild symptoms and management of their contacts. Interim guidance 17 March 2020. WHO reference number: WHO/nCov/IPC/HomeCare/2020.3

12. https://saude.rs.gov.br/upload/arquivos/202002/12090034-coronavirus-isolamento-domiciliar-1.pdf.

13. Markel, Howard, et al. "Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic." Jama 298.6 (2007): 644-654.

14. Wang, Wenling, et al. "Detection of SARS-CoV-2 in Different Types of Clinical Specimens." JAMA (2020).

15. Lai, Shengjie, et al. "Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak: an observational and modelling study." medRxiv (2020).

16. NI, Yue-Nan et al. The effect of corticosteroids on mortality of patients with influenza pneumonia: a systematic review and meta-analysis. Critical Care, v. 23, n. 1, p. 99, 2019.

Comentários (0)